200 related articles for article (PubMed ID: 38243273)
1. Inactivation of pentraxin 3 suppresses M2-like macrophage activity and immunosuppression in colon cancer.
Chen FW; Wu YL; Cheng CC; Hsiao YW; Chi JY; Hung LY; Chang CP; Lai MD; Wang JM
J Biomed Sci; 2024 Jan; 31(1):10. PubMed ID: 38243273
[TBL] [Abstract][Full Text] [Related]
2. Targeting chemotherapy-induced PTX3 in tumor stroma to prevent the progression of drug-resistant cancers.
Chi JY; Hsiao YW; Li CF; Lo YC; Lin ZY; Hong JY; Liu YM; Han X; Wang SM; Chen BK; Tsai KK; Wang JM
Oncotarget; 2015 Sep; 6(27):23987-4001. PubMed ID: 26124179
[TBL] [Abstract][Full Text] [Related]
3. High PTX3 expression is associated with a poor prognosis in diffuse large B-cell lymphoma.
Carreras J; Kikuti YY; Hiraiwa S; Miyaoka M; Tomita S; Ikoma H; Ito A; Kondo Y; Itoh J; Roncador G; Martinez A; Colomo L; Hamoudi R; Ando K; Nakamura N
Cancer Sci; 2022 Jan; 113(1):334-348. PubMed ID: 34706126
[TBL] [Abstract][Full Text] [Related]
4. Cancer-Associated Stromal Fibroblast-Derived Transcriptomes Predict Poor Clinical Outcomes and Immunosuppression in Colon Cancer.
Wang J; Akter R; Shahriar MF; Uddin MN
Pathol Oncol Res; 2022; 28():1610350. PubMed ID: 35991839
[No Abstract] [Full Text] [Related]
5. Pentraxin-3 Silencing Suppresses Gastric Cancer-related Inflammation by Inhibiting Chemotactic Migration of Macrophages.
Choi B; Lee EJ; Park YS; Kim SM; Kim EY; Song Y; Kang SW; Rhu MH; Chang EJ
Anticancer Res; 2015 May; 35(5):2663-8. PubMed ID: 25964543
[TBL] [Abstract][Full Text] [Related]
6. Pentraxin-3 modulates lipopolysaccharide-induced inflammatory response and attenuates liver injury.
Perea L; Coll M; Sanjurjo L; Blaya D; Taghdouini AE; Rodrigo-Torres D; Altamirano J; Graupera I; Aguilar-Bravo B; Llopis M; Vallverdú J; Caballeria J; van Grunsven LA; Sarrias MR; Ginès P; Sancho-Bru P
Hepatology; 2017 Sep; 66(3):953-968. PubMed ID: 28422322
[TBL] [Abstract][Full Text] [Related]
7. Expression of long pentraxin 3 in human nasal mucosa fibroblasts, tissues, and secretions of chronic rhinosinusitis without nasal polyps.
Tsai YJ; Hao CY; Chen CL; Wu PH; Wu WB
J Mol Med (Berl); 2020 May; 98(5):673-689. PubMed ID: 32239253
[TBL] [Abstract][Full Text] [Related]
8. Pentraxin 3 exacerbates psoriasiform dermatitis through regulation of macrophage polarization.
Liu J; Qiu C; Zhou Z; Li J; Zhen Y; Wang R; Zhuang Y; Zhang F
Int Immunopharmacol; 2024 Mar; 130():111805. PubMed ID: 38457930
[TBL] [Abstract][Full Text] [Related]
9. Pentraxin 3 regulated by miR-224-5p modulates macrophage reprogramming and exacerbates osteoarthritis associated synovitis by targeting CD32.
Yin J; Zeng H; Fan K; Xie H; Shao Y; Lu Y; Zhu J; Yao Z; Liu L; Zhang H; Luo B; Wang X; Zeng C; Bai X; Zhang H; Cai D
Cell Death Dis; 2022 Jun; 13(6):567. PubMed ID: 35739102
[TBL] [Abstract][Full Text] [Related]
10. PTX3 mediates the infiltration, migration, and inflammation-resolving-polarization of macrophages in glioblastoma.
Zhang H; Wang Y; Zhao Y; Liu T; Wang Z; Zhang N; Dai Z; Wu W; Cao H; Feng S; Zhang L; Cheng Q; Liu Z
CNS Neurosci Ther; 2022 Nov; 28(11):1748-1766. PubMed ID: 35855654
[TBL] [Abstract][Full Text] [Related]
11. Disruption of the pentraxin 3/CD44 interaction as an efficient therapy for triple-negative breast cancers.
Hsiao YW; Chi JY; Li CF; Chen LY; Chen YT; Liang HY; Lo YC; Hong JY; Chuu CP; Hung LY; Du JY; Chang WC; Wang JM
Clin Transl Med; 2022 Jan; 12(1):e724. PubMed ID: 35090088
[TBL] [Abstract][Full Text] [Related]
12. Pentraxin 3 deficiency protects from the metabolic inflammation associated to diet-induced obesity.
Bonacina F; Moregola A; Porte R; Baragetti A; Bonavita E; Salatin A; Grigore L; Pellegatta F; Molgora M; Sironi M; Barbati E; Mantovani A; Bottazzi B; Catapano AL; Garlanda C; Norata GD
Cardiovasc Res; 2019 Nov; 115(13):1861-1872. PubMed ID: 30859179
[TBL] [Abstract][Full Text] [Related]
13. CPT1C-positive cancer-associated fibroblast facilitates immunosuppression through promoting IL-6-induced M2-like phenotype of macrophage.
Wei R; Song J; Pan H; Liu X; Gao J
Oncoimmunology; 2024; 13(1):2352179. PubMed ID: 38746869
[TBL] [Abstract][Full Text] [Related]
14. β-Carotene exerts anti-colon cancer effects by regulating M2 macrophages and activated fibroblasts.
Lee NY; Kim Y; Kim YS; Shin JH; Rubin LP; Kim Y
J Nutr Biochem; 2020 Aug; 82():108402. PubMed ID: 32450500
[TBL] [Abstract][Full Text] [Related]
15. Constitutive expression of pentraxin 3 (PTX3) protein by human amniotic membrane cells leads to formation of the heavy chain (HC)-hyaluronan (HA)-PTX3 complex.
Zhang S; Zhu YT; Chen SY; He H; Tseng SC
J Biol Chem; 2014 May; 289(19):13531-42. PubMed ID: 24652286
[TBL] [Abstract][Full Text] [Related]
16. Elevated Pentraxin 3 in bone metastatic breast cancer is correlated with osteolytic function.
Choi B; Lee EJ; Song DH; Yoon SC; Chung YH; Jang Y; Kim SM; Song Y; Kang SW; Yoon SY; Chang EJ
Oncotarget; 2014 Jan; 5(2):481-92. PubMed ID: 24457902
[TBL] [Abstract][Full Text] [Related]
17. Selective recognition of fibroblast growth factor-2 by the long pentraxin PTX3 inhibits angiogenesis.
Rusnati M; Camozzi M; Moroni E; Bottazzi B; Peri G; Indraccolo S; Amadori A; Mantovani A; Presta M
Blood; 2004 Jul; 104(1):92-9. PubMed ID: 15031207
[TBL] [Abstract][Full Text] [Related]
18. Ovatodiolide suppresses colon tumorigenesis and prevents polarization of M2 tumor-associated macrophages through YAP oncogenic pathways.
Huang YJ; Yang CK; Wei PL; Huynh TT; Whang-Peng J; Meng TC; Hsiao M; Tzeng YM; Wu AT; Yen Y
J Hematol Oncol; 2017 Feb; 10(1):60. PubMed ID: 28241877
[TBL] [Abstract][Full Text] [Related]
19. Pentraxin-3 inhibits milky spots metastasis of gastric cancer by inhibiting M2 macrophage polarization.
Cui X; Qin T; Zhao Z; Yang G; Sanches JGP; Zhang Q; Fan S; Cao L; Hu X
J Cancer; 2021; 12(15):4686-4697. PubMed ID: 34149932
[No Abstract] [Full Text] [Related]
20. The Cancer-Associated Fibroblasts-Related Gene COMP Is a Novel Predictor for Prognosis and Immunotherapy Efficacy and Is Correlated with M2 Macrophage Infiltration in Colon Cancer.
Ma H; Qiu Q; Tan D; Chen Q; Liu Y; Chen B; Wang M
Biomolecules; 2022 Dec; 13(1):. PubMed ID: 36671447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]